Led Health Technology (Guangzhou) Co., Ltd. has officially declared the successful closure of its Pre-A round financing, raising tens of millions of yuan. This funding round was spearheaded by a globally renowned hard technology investment firm, with Huameng Investment and Rongxinneng Investment joining as co-investors, and WinX Capital acting as the sole financial advisor. Since commencing operations in March 2024, the company has built a diverse, multidisciplinary team and has already rolled out over 10 cutting-edge AI-driven life science instrument products and services, creating a comprehensive suite of systematic product solutions. Looking ahead, the company aims to introduce even more competitive offerings and supply data production tools alongside infrastructure support. Presently, the company has set up a pilot production platform and secured contracts with nearly 100 premier clients. Additionally, it places significant emphasis on intellectual property protection and standardization efforts. Both the lead investor and WinX Capital express strong confidence in the company's growth potential. Founder Zhang Feng remarked that the newly acquired funds will be allocated towards product development and other strategic initiatives, fostering technological self-sufficiency and robustness in this domain, and ultimately delivering solutions that boost efficiency and reduce costs.